Company Filing History:
Years Active: 1998-2008
Title: Margit Richter: Innovator in Pharmaceutical Chemistry
Introduction
Margit Richter is a prominent inventor based in Jena, Germany. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with potential therapeutic applications. With a total of 3 patents, her work has garnered attention for its innovative approach to addressing medical needs.
Latest Patents
One of her latest patents involves the invention of 8β-vinyl-11β-(ω-substituted)alkyl-estra-1,3,5(10)-trienes. This invention relates to compounds that exhibit ERβ-antagonistic activity, along with the processes for their production and their pharmaceutical applications. These new compounds are particularly noteworthy for their potential use in contraception for both men and women, as they do not affect other estrogen-sensitive organs such as the uterus or liver. Additionally, they are suitable for treating benign or malignant proliferative diseases of the ovary, including ovarian cancer and granulosa cell tumors. Another patent focuses on C13-substituted estra-1,3,5,(10)-trien-3-yl sulfamates, detailing methods of preparation and pharmaceutical compositions containing these compounds.
Career Highlights
Throughout her career, Margit Richter has worked with notable companies in the pharmaceutical industry, including Schering Aktiengesellschaft and Jenapharm GmbH & Co. KG. Her experience in these organizations has allowed her to develop and refine her innovative ideas, contributing to advancements in medical treatments.
Collaborations
Margit has collaborated with esteemed colleagues such as Sigfrid Schwarz and Walter Elger. These partnerships have played a crucial role in her research and development efforts, fostering an environment of innovation and creativity.
Conclusion
Margit Richter's contributions to pharmaceutical chemistry highlight her role as a leading inventor in the field. Her innovative patents and collaborations demonstrate her commitment to advancing medical science and improving patient care.